-
Espire Hospitality Announces Results for FY 2026 and Q4-FY26
Espire Hospitality Limited reports its highest ever revenue of ₹14,106 Lakhs in FY 2026, a growth of 17% as compared to FY 2025; and its highest ever EBITDA of ₹3,190 Lakhs, a growth of 38% as compared to FY 2025 The Company has registered a revenue of ₹4,873 Lakhs in Q4-FY26, a growth of 19% as…
-
Texas A&M Study Highlights Pictor PictVet® as a Promising New Tool for Non-Invasive Beef Cattle Health Monitoring
Independent peer-reviewed research published in Frontiers in Veterinary Science reports strong assay performance in a proof-of-concept evaluation using bovine nasopharyngeal swab samples CARLSBAD, Calif., June 22, 2026 /PRNewswire/ — Pictor Holdings Inc., a global targeted proteomic platform company, today highlighted the publication of an independent peer-reviewed study conducted by researchers at Texas A&M University and published…
-
QNET DENIES ANY ASSOCIATION WITH IGNITE
HYDERABAD, India, June 13, 2026 /PRNewswire/ — QNET has taken note of recent media reports published in Telangana concerning the alleged activities of an entity operating under the name IGNITE, as well as references that seek to associate those activities with QNET and its franchisee in India, Vihaan Direct Selling (India) Pvt. Ltd. Given the…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
